Camp4 Therapeutics Corporation (CAMP)
NASDAQ: CAMP · Real-Time Price · USD
3.800
-0.290 (-7.09%)
Nov 13, 2026, 4:00 PM EST - Market closed
Camp4 Therapeutics Stock Forecast
Stock Price Forecast
According to 10 analysts polled by S&P Global, Camp4 Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $10.22. The average 1-year stock price forecast is 168.95% higher than the current stock price, while the lowest is $6.00 (+57.89%) and the highest is $15 (+294.74%).
Price Target: $10.22 (+168.95%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Camp4 Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 7 | 7 |
| Buy | 2 | 2 | 2 | 2 | 3 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 7 | 7 | 10 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| J.P. Morgan | J.P. Morgan | Buy Maintains $9 | Buy | Maintains | $9 | +136.84% | Nov 11, 2026 |
| Wedbush | Wedbush | Buy Maintains $8 | Buy | Maintains | $8 | +110.53% | Nov 6, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $7 | Buy | Maintains | $7 | +84.21% | Nov 6, 2026 |
| Piper Sandler | Piper Sandler | Buy Reiterates $15 | Buy | Reiterates | $15 | +294.74% | Nov 6, 2026 |
| Raymond James | Raymond James | Buy Initiates $10 | Buy | Initiates | $10 | +163.16% | Oct 23, 2026 |
Financial Forecast
Revenue This Year
6.66M
from 3.50M
Increased by 90.52%
Revenue Next Year
6.27M
from 6.66M
Decreased by -5.93%
EPS This Year
-1.21
from -1.65
EPS Next Year
-0.84
from -1.21
EPS and Forward PE are based on non-GAAP adjusted numbers.